RIGEX | VTISX | RIGEX / VTISX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 8 years | - |
Gain YTD | 4.983 | 5.489 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15B | 442B | 3% |
Annual Yield % from dividends | 2.32 | 3.32 | 70% |
Returns for 1 year | 10.23 | 10.54 | 97% |
Returns for 3 years | -4.62 | -3.04 | 152% |
Returns for 5 years | 15.01 | 17.70 | 85% |
Returns for 10 years | 15.61 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 28.09 | 0.31 | +1.11% |
First Trust Nasdaq Pharmaceuticals ETF | |||
ACTV | 33.45 | 0.33 | +1.01% |
LeaderShares® Activist Leaders® ETF | |||
FTCS | 92.82 | 0.65 | +0.71% |
First Trust Capital Strength ETF | |||
PID | 19.28 | 0.10 | +0.52% |
Invesco International Div Achiev ETF | |||
ICLO | 25.61 | 0.01 | +0.04% |
Invesco AAA CLO Floating Rate Note ETF |